These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 1834013

  • 1. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.
    Fantin B, Leclercq R, Arthur M, Duval J, Carbon C.
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1570-5. PubMed ID: 1834013
    [Abstract] [Full Text] [Related]

  • 2. Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F, Kitzis MD, Gutmann L, Cremieux AC, Maziere B, Vallois JM, Saleh-Mghir A, Lemeland JF, Carbon C.
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2611-6. PubMed ID: 1336339
    [Abstract] [Full Text] [Related]

  • 3. [Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
    Pérez Salmerón J, Martínez García F, Roldán Conesa D, Lorente Salinas I, López Fornás F, Ruiz Gómez J, Gómez Gómez J, Segovia Hernández M, Valdés Chávarri M.
    Rev Esp Quimioter; 2006 Sep; 19(3):258-66. PubMed ID: 17099794
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.
    Yao JD, Thauvin-Eliopoulos C, Eliopoulos GM, Moellering RC.
    Antimicrob Agents Chemother; 1990 May; 34(5):827-30. PubMed ID: 2141778
    [Abstract] [Full Text] [Related]

  • 5. Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F, Pestel M, Kitzis MD, Lemeland JF, Humbert G, Gutmann L.
    J Infect Dis; 1995 Jan; 171(1):106-12. PubMed ID: 7798650
    [Abstract] [Full Text] [Related]

  • 6. Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis.
    Lafaurie M, Perichon B, Lefort A, Carbon C, Courvalin P, Fantin B.
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2826-30. PubMed ID: 11557476
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditis.
    Nicolau DP, Marangos MN, Nightingale CH, Patel KB, Cooper BW, Quintiliani R, Courvalin P, Quintiliani R.
    Antimicrob Agents Chemother; 1996 Jan; 40(1):55-60. PubMed ID: 8787879
    [Abstract] [Full Text] [Related]

  • 8. Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecium.
    Lefort A, Garry L, Depardieu F, Courvalin P, Fantin B.
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3515-8. PubMed ID: 14576110
    [Abstract] [Full Text] [Related]

  • 9. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC, Grayson ML, Eliopoulos GM, Bayer AS.
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [Abstract] [Full Text] [Related]

  • 10. In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.
    Reissier S, Saleh-Mghir A, Guerin F, Massias L, Ghout I, Sinel C, Cattoir V, Cremieux AC.
    J Antimicrob Chemother; 2018 Apr 01; 73(4):981-986. PubMed ID: 29329389
    [Abstract] [Full Text] [Related]

  • 11. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
    Lavoie SR, Wong ES, Coudron PE, Williams DS, Markowitz SM.
    Antimicrob Agents Chemother; 1993 Jul 01; 37(7):1447-51. PubMed ID: 8363374
    [Abstract] [Full Text] [Related]

  • 12. Synergy of an investigational glycopeptide, LY333328, with once-daily gentamicin against vancomycin-resistant Enterococcus faecium in a multiple-dose, in vitro pharmacodynamic model.
    Zelenitsky SA, Booker B, Laing N, Karlowsky JA, Hoban DJ, Zhanel GG.
    Antimicrob Agents Chemother; 1999 Mar 01; 43(3):592-7. PubMed ID: 10049272
    [Abstract] [Full Text] [Related]

  • 13. A High Daptomycin Dose Is Associated with Better Bacterial Clearance in Infections Caused by Vancomycin-Resistant Enterococcus faecium Regardless of Daptomycin Minimum Inhibitory Concentration in a Rat Infective Endocarditis Model.
    Wang JT, Yang CJ, Yang JL, Lin SW, Chuang YC, Sheng WH, Chen YC, Chang SC.
    Microbiol Spectr; 2022 Oct 26; 10(5):e0255122. PubMed ID: 36190402
    [Abstract] [Full Text] [Related]

  • 14. Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin-and glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F, Lemeland JF, Humbert G, Klare I, Gutmann L.
    J Infect Dis; 1993 Sep 26; 168(3):681-6. PubMed ID: 8354909
    [Abstract] [Full Text] [Related]

  • 15. Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F, Carbon C, Gutmann L.
    J Infect Dis; 1991 Nov 26; 164(5):888-93. PubMed ID: 1940467
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A, Werth BJ, Barber KE, Sakoulas G, Rybak MJ.
    J Antimicrob Chemother; 2014 Aug 26; 69(8):2148-54. PubMed ID: 24777900
    [Abstract] [Full Text] [Related]

  • 17. Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats.
    Entenza JM, Calandra T, Moosmann Y, Malinverni R, Glauser MP.
    Antimicrob Agents Chemother; 1992 Jun 26; 36(6):1256-62. PubMed ID: 1416824
    [Abstract] [Full Text] [Related]

  • 18. Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.
    Perdikaris GS, Pefanis A, Giamarellou H, Nikolopoulos A, Margaris EP, Donta I, Tsitsika A, Karayiannakos P.
    Antimicrob Agents Chemother; 1997 Sep 26; 41(9):1916-21. PubMed ID: 9303384
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
    Vouillamoz J, Moreillon P, Giddey M, Entenza JM.
    J Antimicrob Chemother; 2006 Dec 26; 58(6):1208-14. PubMed ID: 17030515
    [Abstract] [Full Text] [Related]

  • 20. Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.
    Vazquez J, Perri MB, Thal LA, Donabedian SA, Zervos MJ.
    J Antimicrob Chemother; 1993 Nov 26; 32(5):715-21. PubMed ID: 8125836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.